International Journal of Drug Policy
Volume 20, Issue 3 , Pages 277-282 , May 2009

Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market

Received 8 May 2008 ,Revised 12 August 2008 ,Accepted 14 August 2008.

References 

  1. Centers for Disease Control and Prevention . Update: Clostridium novyi and unexplained illness among injecting-drug users—Scotland, Ireland, and England, April–June 2000. Morbidity and Mortality Weekly Report. 2000;49(24):543–545
  2. Andreas P. Free market reform and drug market prohibition: U.S. policies at cross-purposes in Latin America. Third World Quarterly. 1995;16(1):75–87
  3. Andreas P. U.S.-Mexico: open markets, closed border. Foreign Policy. 1996;103(2):51–69
  4. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance—United States, 1995–1997. MMWR CDC Surveillance Summaries. 1998;47(2):1–13
  5. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clinical Infectious Diseases. 2000;30(3):579–581
  6. Bowden M. Killing Pablo: The hunt for the world’s greatest outlaw. New York: Atlantic Monthly Press; 2001;
  7. Bryant WK, Galea S, Tracy M, Markham Piper T, Tardiff KJ, Vlahov D. Overdose deaths attributed to methadone and heroin in New York City, 1990–1998. Addiction. 2004;99(7):846–854
  8. Bucardo J, Brouwer KC, Magis-Rodriguez C, Ramos R, Fraga M, Perez SG, et al. Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections. Drug and Alcohol Dependence. 2005;79(3):281–293
  9. Bureau of Transportation Statistics & Research and Innovative Technology Administration. (2007). Retrieved November 1 from http://www.transtats.bts.gov.
  10. Central Intelligence Agency. (2007). The World Factbook. Retrieved August 29, 2007, from https://www.cia.gov/library/publications/the-world-factbook/index.html.
  11. Ciccarone D. The political economy of heroin: Regional markets, practices and consequences. International Journal of Drug Policy. 2005;17(5):289–290
  12. Ciccarone D, Bamberger J, Kral A, Edlin B, Hobart C, Moon A, et al. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Morbidity and Mortality Weekly Report. 2001;50(19):381–384
  13. Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Substance Use and Misuse. 2003;38(14):2049–2063
  14. Cooper HL, Brady JE, Ciccarone D, Tempalski B, Gostnell K, Friedman SR. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clinical Infectious Diseases. 2007;45(9):1200–1203
  15. DEA Congressional Testimony by Thomas A. Constantine, Administrator, Drug Enforcement Administration. (1996). Before the: House Subcommittee on the Western Hemisphere & House International Relations Committee. Regarding: Drug Control in the Western Hemisphere. June 6, 1996.
  16. DEA Congressional Testimony by James Milford Deputy Administrator Drug Enforcement Administration. (1997). Before the: The House International Relations Committee Subcommittee on the Western Hemisphere Regarding: Western Hemisphere. July 16, 1997.
  17. Degenhardt L, Reuter P, Collins L, Hall W. Evaluating explanations of the Australian ‘heroin shortage’. Addiction. 2005;100(4):459–469
  18. Dermota, K. (2007). Snow fall: Attacking cocaine at its source was meant to drive up prices, yet U.S. street dealers are selling it for less than ever. The Atlantic Monthly, 300.
  19. Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: Droughts, gluts or cycles?. Drug and Alcohol Review. 2002;21(3):295–303
  20. Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infectious Disease Clinics of North America. 2002;16(3):697–712
  21. The Economist (2007). Mexico and the United States: Plan Mexico. Agreement nears on anti-drug aid, 384, 32.
  22. Frank B. An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine. 2000;67(5–6):340–346
  23. Gibson A, Degenhardt L, Day C, McKetin R. Recent trends in heroin supply to markets in Australia, the United States and Western Europe. International Journal of Drug Policy. 2005;16(5):293–299
  24. Gordon RJ, Lowy FD. Bacterial infections in drug users. The New England Journal of Medicine. 2005;353(18):1945–1954
  25. Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Archives of Surgery. 2002;137(11):1217–1222
  26. House Committee on Foreign Affairs. (1973). The U.S. Heroin Problem and Southeast Asia. Report of a Staff Survey Team of the House Committee on Foreign Affairs, United States House of Representatives. January 11, 1973.
  27. Kimura AC, Higa JI, Levin RM, Simpson G, Vargas Y, Vugia DJ. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clinical Infectious Diseases. 2004;38(9):e87–e91
  28. Kline HF. Colombia: Democracy under assault. Boulder, CO: Westview; 1995;
  29. McCoy AW, Read CB, Adams LP. The politics of heroin in Southeast Asia. New York: Harper & Row; 1972;
  30. Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: A case-control study. Clinical Infectious Diseases. 2001;33(1):35–40
  31. National Drug Intelligence Center . Interagency Domestic Heroin Threat Assessment, February 2000. Johnstown, PA: National Drug Intelligence Center; 2000;
  32. National Narcotics Intelligence Consumers Committee . NNICC Report 1991: The supply of illicit drugs to the United States. Arlington, VA: NNICC; 1992;
  33. Oxman G, Kowalski S, Drapela L, Gray ES, Fafara S. Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morbidity and Mortality Weekly Report. 2000;49(28):633–636
  34. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. Journal of the American Medical Association. 1998;279(11):859–863
  35. President’s Commission on Organized Crime. (1986). America’s habit: Drug abuse, drug trafficking, and organized crime: Report to the President and the Attorney General. Washington, DC: Commission on Organized Crime.
  36. Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS. 1998;12(17):2345–2350
  37. Springer, N. (2006). Colombia: Internal Displacement—Policies and Problems: United Nations High Commissioner for Refugees, Status Determination and Protection Information Section.
  38. Strang J, Griffiths P, Gossop M. Heroin smoking by ‘chasing the dragon’: Origins and history. Addiction. 1997;92(6):673–683[discussion 685–695]
  39. Substance Abuse and Mental Health Services Administration: Office of Applied Studies . New Heroin Users Admitted to Treatment: 1992–2000. Rockville, MD: Substance Abuse and Mental Health Services Administration: Office of Applied Studies; 2003;
  40. Substance Abuse and Mental Health Services Administration: Office of Applied Studies . The DASIS Report, December 3, 2004. Characteristics of Primary Heroin Injection and Inhalation Admissions: 2002. Rockville, MD: Substance Abuse and Mental Health Services Administration: Office of Applied Studies; 2004;
  41. The Office of the United Nations High Commissioner for Refugees . Internally Displaced People: Questions and Answers. Geneva, CHE: UNHCR Media Relations and Public Information Service; 2007;
  42. The White House: Office of National Drug Control and Policy . National Drug Control Strategy, FY 2005 Budget Summary. Washington, DC: The White House: Office of National Drug Control Policy; 2004;
  43. Thoumi FE. Illegal drugs in Colombia: From illegal economic boom to social crisis. Annals of the American Academy of Political and Social Science. 2002;582(1):102–116
  44. Toro MC. The internationalization of police: The DEA in Mexico. The Journal of American History. 1999;86(2):623–640
  45. United Nations Office for Drug Control, Crime Prevention . Global Illicit Drug Trends 1999. New York: United Nations Office for Drug Control and Crime Prevention; 1999;
  46. United Nations Office on Drugs and Crime. (2000). 2000 World Drug Report. Oxford: United Nations Office on Drugs and Crime.
  47. United Nations Office on Drugs and Crime . Global Illicit Drug Trends 2003. Vienna: United Nations Office on Drugs and Crime; 2003;
  48. United Nations Office on Drugs and Crime . 2007 Afghanistan Opium Survey. Kabul: United Nations Office on Drugs and Crime; 2007;
  49. United Nations Office on Drugs and Crime. (2007b). 2007 World Drug Report. Vienna: United Nations Office on Drugs and Crime.
  50. United Nations Office on Drugs and Crime Country Office for Afghanistan. (2008). Illicit Drug Trends in Afghanistan.
  51. US Department of Justice, & National Drug Intelligence Center . The Availability of Southwest Asian Heroin in the United States: A Market Analysis. Washington, DC: US Department of Justice, & National Drug Intelligence Center; 2007;
  52. US Domestic Council Drug Abuse Task Force. (1975). White paper on drug abuse, September 1975, a report to the President from the Domestic Council Drug Abuse Task Force. Washington, DC: US Domestic Council Drug Abuse Task Force.
  53. US Drug Enforcement Administration. (1991). Domestic Monitor Program: A Fiscal Year 1990 Report on the Source of Origin, Cost and Purity of Retail Level Heroin. Washington, DC: Domestic Unit, Strategic Intelligence Section, Drug Enforcement Administration.
  54. US Drug Enforcement Administration . Coca cultivation and cocaine processing: An overview. Washington, DC: Drug Enforcement Administration; 1993;
  55. US Drug Enforcement Administration. (1995). News Release, For Immediate Release, June 21, 1995. Colombian Heroin a Major Threat. Almost One Third of Heroin Seized in the United States Originates in South America. Retrieved July 31, 2007, from http://web.archive.org/web/20030427085041/ww0w.usdoj.gov/dea/pubs/pressrel/pr950621.htm.
  56. US Drug Enforcement Administration . The South American Cocaine Trade: An “Industry” in Transition. Washington, DC: Drug Enforcement Administration; 1996;
  57. US Drug Enforcement Administration. (2000). DEA Briefing Book. Retrieved September 10, 2007, from http://web.archive.org/web/20010124073400/www.dea.gov/briefingbook/index.html.
  58. US Drug Enforcement Administration . Domestic Monitor Program 1999–2000. Washington, DC: Domestic Strategic Unit, Domestic Intelligence Section, Office of Domestic Intelligence; 2002;
  59. US Drug Enforcement and Administration . Drug Enforcement Administration: A Tradition of Excellence 1973–2003. Washington, DC: US Department of Justice, Drug Enforcement Administration; 2005;
  60. US Drug Enforcement and Administration . 2006 Domestic Monitor Program. Washington, DC: Domestic Strategic Intelligence Unit, Special Strategic Intelligence Section; 2007;
  61. Weatherburn DJC, Freeman K, Makkai T. Supply control and harm reduction: Lessons from the Australian heroin ‘Drought’. Addiction. 2003;98(1):83–91
  62. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951–1998: Recent epidemic in heroin injectors. Clinical Infectious Diseases. 2000;31(4):1018–1024
  63. Williamson N, Archibald C, Van Vliet JS. Unexplained deaths among injection drug users: A case of probable Clostridium myonecrosis. Canadian Medical Association Journal. 2001;165(5):609–611
  64. Wood E, Stoltz JA, Li K, Montaner JS, Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction. 2006;101(5):689–695

PII: S0955-3959(08)00173-4

doi: 10.1016/j.drugpo.2008.08.003

International Journal of Drug Policy
Volume 20, Issue 3 , Pages 277-282 , May 2009

Article Tools